Drugs / EDTA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06365762 | Jan → Dec 2006 | cataract | Livionex Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EDTA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06365762 ↗ |
| Known as | C-KAD | “To evaluate the efficacy of EDTA 1.3% and 2.6% ophthalmic solution (C-KAD) in improving visual function as assessed by contrast sensitivity” NCT06365762 ↗ |